RMDA.CA

Share Price

EGP 4.89 /Share

1.03%

High:EGP 4.94
Low:EGP 4.85
Open:EGP 4.84
Close:EGP 4.89

Last trade 23/01/2020 02:29PM
Data delayed 15-20 min

Details

Rameda is the fastest growing pharmaceutical company in Egypt and is principally engaged in the manufacture and sale of a wide range of branded generic pharmaceutical products. Today, we are predominately focused on six therapeutic areas: systemic anti-infectives, alimentary tract and metabolism, genitourinary system and sex hormones, cardiovascular system, nervous system, and blood and blood-forming organs.

The fastest growing pharmaceutical company in Egypt

measured by its sales value CAGR from 2013 to 2018

105 marketed products

relating to 71 molecules (including registered molecules and those in the customary process of re-registration)

354 products in the pipeline

relating to 219 molecules, across 11 of the 16 therapeutic areas in the Egyptian pharmaceutical industry

Latest Earnings

04 Dec 2019

Latest IR presentation

N/A

10 Dec 2019